ITGAM and neoplasm: Candesartan decreased the immune suppression function of tumor-associated CD11b+ T cells and decreased their production of VEGF and arginase, and increased interferon-γ synthesis in the lymph nodes of colon-cancer-bearing mice, without having effect on in vivo tumor growth [326].